These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3061771)
1. Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestation. Morley CJ; Greenough A; Miller NG; Bangham AD; Pool J; Wood S; South M; Davis JA; Vyas H Early Hum Dev; 1988 May; 17(1):41-54. PubMed ID: 3061771 [TBL] [Abstract][Full Text] [Related]
2. Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group. Br Med J (Clin Res Ed); 1987 Apr; 294(6578):991-6. PubMed ID: 2890398 [TBL] [Abstract][Full Text] [Related]
3. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome. Morley CJ Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic treatment of premature babies with artificial surfactant (ALEC). Morley CJ Dev Pharmacol Ther; 1989; 13(2-4):182-3. PubMed ID: 2612300 [TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R; Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380 [TBL] [Abstract][Full Text] [Related]
6. Surfactant substitution in the newborn by application of artificial surfactant. Morley CJ J Perinat Med; 1987; 15(5):469-78. PubMed ID: 3327939 [TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R; Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381 [TBL] [Abstract][Full Text] [Related]
8. Neonatal respiratory distress syndrome and surfactant therapy; a brief review. Robertson B Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999 [TBL] [Abstract][Full Text] [Related]
9. Use of surfactant for prophylaxis versus rescue treatment of respiratory distress syndrome: experience from an Italian-Bulgarian trial. Bevilacqua G; Chernev T; Parmigiani S; Iarakova N; Gaioni L; Volante E; Gambini L; Bussolati G Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():47-54. PubMed ID: 10021717 [TBL] [Abstract][Full Text] [Related]
10. An observational study of surfactant treatment in infants of 23-30 weeks' gestation: comparison of prophylaxis and early rescue. Bevilacqua G; Parmigiani S; J Matern Fetal Neonatal Med; 2003 Sep; 14(3):197-204. PubMed ID: 14694975 [TBL] [Abstract][Full Text] [Related]
11. Respiratory compliance in premature babies treated with artificial surfactant (ALEC). Morley CJ; Greenough A Arch Dis Child; 1991 Apr; 66(4):467-71. PubMed ID: 2031602 [TBL] [Abstract][Full Text] [Related]
12. Artificial reconstituted pulmonary surfactant in prevention and treatment of respiratory distress syndrome in neonates. Jiang ZQ; Sun GM; Ma YM Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):182-4. PubMed ID: 10072978 [TBL] [Abstract][Full Text] [Related]
14. Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. Pfister RH; Soll RF; Wiswell T Cochrane Database Syst Rev; 2007 Jul; (3):CD006069. PubMed ID: 17636826 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091 [TBL] [Abstract][Full Text] [Related]
16. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS. Stevens TP; Blennow M; Soll RF Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469 [TBL] [Abstract][Full Text] [Related]
17. Lung surfactant for replacement therapy. Robertson B Clin Physiol; 1983 Apr; 3(2):97-110. PubMed ID: 6342912 [TBL] [Abstract][Full Text] [Related]
18. Use of surfactant for prevention of respiratory distress syndrome in newborn infants in spontaneous breathing. A randomized multicentre clinical pilot-study. Dambeanu JM; Parmigiani S; Marinescu B; Bevilacqua G Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():39-45. PubMed ID: 10021716 [TBL] [Abstract][Full Text] [Related]
19. Bovine Surfactant Replacement Therapy in Neonates of Less than 32 Weeks' Gestation: A Multicenter Controlled Trial of Prophylaxis versus Early Treatment in China--a Pilot Study. Kong X; Cui Q; Hu Y; Huang W; Ju R; Li W; Wang R; Xia S; Yu J; Zhu T; Feng Z Pediatr Neonatol; 2016 Feb; 57(1):19-26. PubMed ID: 26059103 [TBL] [Abstract][Full Text] [Related]
20. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. Soll RF; Hoekstra RE; Fangman JJ; Corbet AJ; Adams JM; James LS; Schulze K; Oh W; Roberts JD; Dorst JP Pediatrics; 1990 Jun; 85(6):1092-102. PubMed ID: 2187176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]